The presence of PR in tumors generally indicates a more favorable prognosis. In breast cancer, PR positivity often correlates with a lower likelihood of aggressive disease and a better response to hormone therapy. Similarly, in endometrial cancer, PR positivity is associated with better outcomes and may influence the choice of conservative management options.
